Revolution Medicines, Inc. (RVMD) is a Healthcare stock tracked by StreetAlpha. It last closed at $203.77 on Sep 11, down 5.42% on the day. RVMD reports earnings on Wed, Nov 4, 2026. The average 12-month price target from 15 analysts is $260.27 (+27.7% from the last close), with a high of $320.00 and a low of $179.00. Analyst consensus is Strong Buy, based on the latest ratings from 15 firms (14 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in RVMD, 50% of them bullish and 50% bearish. In the past 30 days there were 12 dark pool prints totaling $25.8M, the largest $5.5M.
Each firm's latest rating on RVMD in the past 90 days
Average 12-month target
$260.27
▲ 27.7% upside
Based on 15 analysts who set a price target on RVMD in the past 90 days. The average target is $260.27, with a high of $320.00 and a low of $179.00, compared with the last close of $203.77.
Highest target$320.00
Average target$260.27
Lowest target$179.00
Latest rating changes
Brookline CapitalInitiated
Sep 28Buy$318
Goldman SachsReinstated
Sep 24Buy$267
B of A SecuritiesMaintained
Sep 21Buy$265
Morgan StanleyInitiated
Sep 10Buy$255
StifelTarget raised
Sep 9Buy$85 → $230
Date
Firm
Action
Rating
Price target
Sep 28
Brookline Capital
Initiated
Buy
$318
Sep 24
Goldman Sachs
Reinstated
Buy
$267
Sep 21
B of A Securities
Maintained
Buy
$265
Sep 10
Morgan Stanley
Initiated
Buy
$255
Sep 9
Stifel
Target raised
Buy
$85 → $230
Loading…
Whale Options Flow
90D
Total alerts
2
Bullish
1
50%
Bearish
1
50%
Date span
Jul 27 – Aug 24
Loading…
Dark Pool
30D
Prints
12
Notional
$25.8M
Largest print
$5.5M
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RVMD is in one of them and how their past RVMD trades turned out.
